Other studies on curcumin have shown that in glioma [131], breast [130], gastric [132], and hepatocellular [136] cancers, this natural compound reduces the aggressiveness of cancer cells by inhibiting the expression of H19, an oncogenic lncRNA also involved in the cisplatin response from melanoma cells [87]. The gene discussed is H19; the disease is central nervous system cancer.